We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
+49.88%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$5.33B
AUM Growth
+$851M
Cap. Flow
+$41.1M
Cap. Flow %
0.77%
Top 10 Hldgs %
79.43%
Holding
93
New
17
Increased
12
Reduced
17
Closed
13

Top Buys

Rank Stock Value
1
MBLY
Mobileye N.V.
MBLY
+$15.6M
2
V icon
Visa
V
+$13.6M
3
JPM icon
JPMorgan Chase
JPM
+$13M
4
CELG
Celgene Corp
CELG
+$11.6M
5
YUM icon
Yum! Brands
YUM
+$10.9M

Top Sells

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$17.2M
2
BAC icon
Bank of America
BAC
+$15.6M
3
LNKD
LinkedIn Corporation
LNKD
+$5.67M
4
KITE
Kite Pharma, Inc.
KITE
+$2.82M
5
NKTR icon
Nektar Therapeutics
NKTR
+$2.74M

Sector Composition

Rank Sector Weight
1 Consumer Staples 40.39%
2 Healthcare 20%
3 Consumer Discretionary 13.89%
4 Financials 1.45%
5 Technology 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLUE
26
DELISTED
bluebird bio
BLUE
$23.1M 0.43%
27,792
+3,474
+14% +$3.47M
LNKD
27
DELISTED
LinkedIn Corporation
LNKD
$22.5M 0.42%
100,000
-25,000
-20% -$5.67M
YUM icon
28
Yum! Brands
YUM
$42.2B
$21.9M 0.41%
417,300
+208,650
+100% +$10.9M
IONS icon
29
Ionis Pharmaceuticals
IONS
$9.1B
$21.7M 0.41%
350,000
-50,000
-13% -$2.7M
KITE
30
DELISTED
Kite Pharma, Inc.
KITE
$21.6M 0.4%
350,000
-40,000
-10% -$2.82M
ENDP
31
CALL
DELISTED
Endo International plc
ENDP
$18.4M 0.34%
300,000
-200,000
-40% -$12.2M
YUM icon
32
CALL
Yum! Brands
YUM
$42.2B
$18.3M 0.34%
347,750
– –
AGIO icon
33
Agios Pharmaceuticals
AGIO
$2.1B
$17.9M 0.34%
275,000
+50,000
+22% +$3.28M
ARRY
34
DELISTED
Array Biopharma Inc
ARRY
$15.7M 0.29%
3,710,000
– –
GE icon
35
CALL
GE Aerospace
GE
$368B
$15.6M 0.29%
104,331
-312,993
-75% -$44.5M
MBLY
36
DELISTED
Mobileye N.V.
MBLY
$14.8M 0.28%
+350,000
New +$15.6M
MU icon
37
CALL
Micron Technology
MU
$903B
$14.2M 0.27%
1,000,000
– –
GM icon
38
General Motors
GM
$82.5B
$13.6M 0.26%
400,000
-50,000
-11% -$1.74M
V icon
39
Visa
V
$701B
$13.6M 0.25%
+175,000
New +$13.6M
JPM icon
40
JPMorgan Chase
JPM
$928B
$13.2M 0.25%
+200,000
New +$13M
C icon
41
CALL
Citigroup
C
$216B
$12.9M 0.24%
250,000
-300,000
-55% -$15.9M
CELG
42
DELISTED
Celgene Corp
CELG
$12M 0.22%
+100,000
New +$11.6M
HAPN
43
Happen Inc
HAPN
$2.15B
$11.9M 0.22%
215,000
-20,000
-9% -$1.33M
XBI icon
44
CALL
State Street SPDR S&P Biotech ETF
XBI
$10B
$10.5M 0.2%
150,000
-300,000
-67% -$20.5M
BMRN icon
45
CALL
BioMarin Pharmaceuticals
BMRN
$12B
$10.5M 0.2%
100,000
– –
TWX
46
CALL
DELISTED
Time Warner Inc
TWX
$9.7M 0.18%
150,000
– –
MS icon
47
Morgan Stanley
MS
$322B
$9.54M 0.18%
300,000
+50,000
+20% +$1.66M
KITE
48
CALL
DELISTED
Kite Pharma, Inc.
KITE
$9.24M 0.17%
150,000
– –
APTV icon
49
Aptiv
APTV
$12.5B
$8.57M 0.16%
+100,000
New +$8.36M
JUNO
50
DELISTED
Juno Therapeutics, Inc.
JUNO
$8.35M 0.16%
190,000
-45,000
-19% -$2.23M
1
2
3 4

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q4 2015 Portfolio in Review

As of Q4 2015, Artal Group held 93 positions worth $5.33B, up 19% from $4.48B the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Artal Group's Q4 2015 filing shows 17 new, 12 increased, 17 reduced and 13 closed positions. Its largest new stake was Mobileye N.V.: 350,000 shares worth $14.8M. The largest sale was BioMarin Pharmaceuticals, an estimated $17.2M.

By sector, the portfolio is most concentrated in Consumer Staples at 40% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Artal Group's largest Q4 2015 buy was Mobileye N.V.: 350,000 shares worth $14.8M.
  • Artal Group added most to Yum! Brands in Q4 2015, an estimated $10.9M increase.
  • Artal Group's biggest Q4 2015 reduction was BioMarin Pharmaceuticals, cutting an estimated $17.2M.
  • Artal Group fully exited Bank of America in Q4 2015, selling an estimated $15.6M.
  • Artal Group's ten largest holdings make up 79% of its $5.33B portfolio in Q4 2015.
  • Artal Group opened 17 new positions and closed 13 in Q4 2015.
  • Artal Group's portfolio value rose 19% quarter-over-quarter to $5.33B.

Based on Artal Group's 13F filing for Q4 2015, filed 12 Feb 2016.